Joint Corp Stock Price, News & Analysis

The Joint Corp. (NASDAQ: JYNT), the largest chiropractic care provider in the U.S., will release its first quarter 2023 financial results on May 4, 2023, post-market close. A conference call featuring President and CEO Peter D. Holt and CFO Jake Singleton is scheduled for 5:00 p.m. EDT to discuss these results. Interested attendees can join the call by calling (833) 630-0823 or (412) 317-1831 around 15 minutes before the start time. Additionally, the live webcast with a slide presentation will be available on their investor relations website and archived for one year. The Joint Chiropractic operates over 800 locations nationwide, promoting accessible and affordable chiropractic care without insurance requirements, and has received various accolades for its business model.

The Joint Corp. (NASDAQ: JYNT) announced that franchisees Noah Stone and Vy Tran have been awarded the prestigious Franchisee of the Year by the International Franchise Association (IFA) at its 63rd Annual Convention in Las Vegas on March 28, 2023. The couple operates nine clinics in Houston, consistently ranking among the top performers for sales and patient acquisition across The Joint's network of over 800 locations. The award highlights their exemplary service to the community and contributions to the franchise industry. Stone also serves on the National Franchisee Advisory Board, showcasing their leadership and commitment to the brand.

The Joint Corp. (NASDAQ: JYNT) has signed its first franchise agreement outside the continental U.S., planning to open two clinics in Puerto Rico, targeting South San Juan and Guaynabo. The first clinic is set to open in Fall 2023. The Comerfords, who have a background in chiropractic care, expressed enthusiasm about bringing affordable chiropractic services to Puerto Rico. The Joint Chiropractic is recognized for its no-appointment, no-insurance model, making it a leader in retail chiropractic care with over 800 locations across the U.S. and ranked among top franchises in various business lists.

The Joint Corp. (NASDAQ: JYNT) announced that board member James H. Amos, Jr. will not seek reelection at the 2023 Annual Meeting of Stockholders on May 25, 2023. This decision will reduce the board to six members until a replacement is found. Lead Director Matthew Rubel acknowledged Amos's contributions, highlighting a sixfold increase in system-wide sales from $70.1 million in 2015 to $435.3 million in 2022. The company, with over 800 clinics, aims to expand its footprint in the chiropractic industry, despite challenges such as a nationwide labor shortage and inflationary pressures.

The Joint Corp. (NASDAQ: JYNT) reported a strong financial performance for Q4 and the full year 2022, with Q4 revenue increasing by 26% to $27.8 million compared to Q4 2021, and full-year revenue growing 26% to $101.9 million. The company achieved net income of $547,000 in Q4, reversing a loss from the previous year, and total system-wide sales rose 18% to $120.1 million. The clinic count grew to 838 by year-end. For 2023, management projects revenue between $123 million and $128 million and adjusted EBITDA of $12.5 million to $14 million. The company plans to open 100-120 franchised clinics and 8-12 company-owned clinics.

The Joint Corp. (NASDAQ: JYNT), a leading chiropractic clinic operator, will attend the 35th Annual Roth Conference on March 13-14, 2023, at The Ritz-Carlton, Laguna Niguel, CA. President and CEO Peter Holt and CFO Jake Singleton will engage in a fireside chat with analyst George Kelly on March 14 at 9:30 AM PT. They will also host one-on-one meetings on March 13 and 14. Investors interested in participating should reach out to their ROTH representative or contact Kirsten Chapman at LHA Investor Relations. A live webcast of the presentation will be available for 90 days on the company's investor relations website.